Ticker | Featuring Avecho CEO, Dr Paul Gavin
In this Ticker interview, Avecho CEO Dr Paul Gavin unpacks the current state of the research and development race for CBD in Australia - and his foundations for success, leveraging Avecho's origins and specialist expertise in the biotechnology sector.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Avecho Biotechnology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Avecho Biotechnology a question about this update.